Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Garenoxacin vs Levofloxacin in Community-Acquired Pneumonia
jRCT2080221655Phase 3
- Sponsor
- Fujifilm
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of garenoxacin in community-acquired pneumonia (CAP) (2 arms), sponsored by Fujifilm.
02
Drugs
garenoxacin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on jRCT2080221655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221655.